arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 3/2009 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Globalisation of the clinical research: export of risks

    NEW ON THE MARKET

    Ranolazin (RANEXA) for angina pectoris

    THERAPY FROM A CRITICAL VIEWPOINT

    Mass vaccination with pneumococcal conjugate vaccine PREVENAR - first data from Europe

    a-t READER'S QUESTIONS AND COMMENTS

    Ginkgo biloba useful for dementia?

    CURRENT ADR NETWORK REPORT

    Nightmares on CSE inhibitors
    free

    IN BRIEF

    Prasugrel, Lilly and FDA - exclusion of an expert following a phone call

    SIDE EFFECTS

    Long term metoclopramide: tardive dyskinesia

    Guillain-Barré syndrome after HPV-vaccination

    Tibolone (LIVIELLA) increases the risk of breast cancer recurrence

    Efalizumab (RAPTIVA): suspension of marketing authorisation recommended

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles